| Application no. and date | 19706271.4 (espacenet) (Federated) (European Patent Register), 20190220 | | Patent/reg. no. and date | DK/EP 3755688, 20230614 | | Publication date | 20201230 | | Priority no. and date | EP 18461519, 20180221 | | EP pub. no. and date |
EP 3755688 20201230 | | Effective date | | | Applicant/owner | Adamed Pharma S.A., Pienkow ul. Mariana Adamkiewicza 6A
05-152 Czosnow, PL | | Applicant ref. no. | BB223124EPDK | | Inventor | KOLACZKOWSKI, Marcin, ul. Lany 2
32-020 Wieliczka, PL,
SNIECIKOWSKA, Joanna, ul. Dluga 22C/1
32-020 Wieliczka, PL,
BUCKI, Adam, Przebieczany 558c
32-020 Przebieczany, PL,
MARCINKOWSKA, Monika, ul.Na mostkach 3
31-267 Krakow, PL | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61P 25/00 (2006.01) , A61P 25/16 (2006.01) , A61P 25/18 (2006.01) , A61P 25/24 (2006.01) , A61P 25/28 (2006.01) , C07D 209/10 (2006.01) , C07D 235/10 (2006.01) | | Title | INDOL- OG BENZIMIDAZOLDERIVATER SOM DOBBELTE 5-HT2A- OG 5-HT6-RECEPTORANTAGONISTER | | Int. application no. | EP2019054171 | | Int. publication no. | WO2019162306 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
